How TKI cancer drugs cause inflammatory side effects
Tyrosine kinase inhibitors (TKI) are employed to attack specific types of cancer cells. The downside to using TKs is that they can cause serious inflammation. A team of researchers has discovered the underlying mechanism that causes this inflammation.
Materials provided by Tohoku University. Note: Content may be edited for style and length.
Source link aaaaa